Free Trial

TransMedics Group (TMDX) Competitors

TransMedics Group logo
$70.32 -0.47 (-0.66%)
Closing price 03/26/2025 04:00 PM Eastern
Extended Trading
$70.80 +0.48 (+0.68%)
As of 03/26/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TMDX vs. STVN, GKOS, BLCO, INSP, NARI, PRCT, IRTC, NVST, SLNO, and ENOV

Should you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Envista (NVST), Soleno Therapeutics (SLNO), and Enovis (ENOV). These companies are all part of the "medical equipment" industry.

TransMedics Group vs.

Stevanato Group (NYSE:STVN) and TransMedics Group (NASDAQ:TMDX) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, community ranking, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

Stevanato Group has higher revenue and earnings than TransMedics Group. Stevanato Group is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group$1.10B5.76$157.62M$0.4843.75
TransMedics Group$441.54M5.36-$25.03M$1.0169.62

In the previous week, TransMedics Group had 46 more articles in the media than Stevanato Group. MarketBeat recorded 55 mentions for TransMedics Group and 9 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.27 beat TransMedics Group's score of 0.18 indicating that Stevanato Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stevanato Group
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
TransMedics Group
9 Very Positive mention(s)
4 Positive mention(s)
34 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Neutral

99.7% of TransMedics Group shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by insiders. Comparatively, 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

TransMedics Group has a consensus target price of $122.70, suggesting a potential upside of 74.49%. Given TransMedics Group's stronger consensus rating and higher possible upside, analysts clearly believe TransMedics Group is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
TransMedics Group
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.82

TransMedics Group received 82 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 62.50% of users gave Stevanato Group an outperform vote while only 58.95% of users gave TransMedics Group an outperform vote.

CompanyUnderperformOutperform
Stevanato GroupOutperform Votes
30
62.50%
Underperform Votes
18
37.50%
TransMedics GroupOutperform Votes
112
58.95%
Underperform Votes
78
41.05%

Stevanato Group has a net margin of 10.47% compared to TransMedics Group's net margin of 8.14%. TransMedics Group's return on equity of 18.74% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group10.47% 9.86% 5.79%
TransMedics Group 8.14%18.74%4.39%

Stevanato Group has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500.

Summary

TransMedics Group beats Stevanato Group on 12 of the 19 factors compared between the two stocks.

Remove Ads
Get TransMedics Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDX vs. The Competition

MetricTransMedics GroupElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.37B$3.22B$5.63B$8.13B
Dividend YieldN/A1.61%4.55%4.00%
P/E Ratio74.8114.9524.5019.08
Price / Sales5.3642.19385.3094.58
Price / Cash530.0844.0938.1634.64
Price / Book16.743.346.954.36
Net Income-$25.03M$89.74M$3.20B$247.23M
7 Day Performance2.15%-1.84%-2.18%-0.32%
1 Month Performance-2.50%-9.41%3.15%-3.60%
1 Year Performance-5.13%-15.98%11.29%2.01%

TransMedics Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDX
TransMedics Group
2.6305 of 5 stars
$70.32
-0.7%
$122.70
+74.5%
-5.6%$2.37B$441.54M74.81210Analyst Forecast
STVN
Stevanato Group
1.6841 of 5 stars
€22.57
+0.3%
N/A-33.9%$6.84B$1.10B48.024,650Positive News
GKOS
Glaukos
4.5493 of 5 stars
$108.07
+5.7%
$163.25
+51.1%
+15.0%$6.12B$383.48M-37.68780Positive News
BLCO
Bausch + Lomb
3.8887 of 5 stars
$15.98
+2.7%
$20.00
+25.2%
-7.4%$5.63B$4.79B-17.5612,500
INSP
Inspire Medical Systems
4.8975 of 5 stars
$169.73
+2.9%
$228.82
+34.8%
-21.5%$5.05B$802.80M98.131,246Positive News
NARI
Inari Medical
1.0482 of 5 stars
$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800News Coverage
PRCT
PROCEPT BioRobotics
2.4904 of 5 stars
$60.72
+4.5%
$94.29
+55.3%
+34.2%$3.33B$224.50M-31.14430
IRTC
iRhythm Technologies
2.0892 of 5 stars
$105.89
+1.3%
$119.73
+13.1%
-8.7%$3.32B$591.84M-29.041,790News Coverage
Positive News
NVST
Envista
4.1622 of 5 stars
$17.36
+4.2%
$20.18
+16.3%
-15.5%$3.00B$2.51B-2.6912,700
SLNO
Soleno Therapeutics
4.4315 of 5 stars
$49.52
+0.8%
$71.20
+43.8%
+13.4%$2.29BN/A-15.0330Positive News
ENOV
Enovis
3.4568 of 5 stars
$39.97
+2.3%
$58.50
+46.3%
-35.0%$2.28B$2.11B-18.276,550Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:TMDX) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners